A. S. Emekli, "Amiselimod: A New Oral Agent in the Treatment of Multiple Sclerosis," TURKISH JOURNAL OF NEUROLOGY , vol.23, no.3, pp.148-149, 2017
Emekli, A. S. 2017. Amiselimod: A New Oral Agent in the Treatment of Multiple Sclerosis. TURKISH JOURNAL OF NEUROLOGY , vol.23, no.3 , 148-149.
Emekli, A. S., (2017). Amiselimod: A New Oral Agent in the Treatment of Multiple Sclerosis. TURKISH JOURNAL OF NEUROLOGY , vol.23, no.3, 148-149.
Emekli, Ahmed. "Amiselimod: A New Oral Agent in the Treatment of Multiple Sclerosis," TURKISH JOURNAL OF NEUROLOGY , vol.23, no.3, 148-149, 2017
Emekli, Ahmed S. . "Amiselimod: A New Oral Agent in the Treatment of Multiple Sclerosis." TURKISH JOURNAL OF NEUROLOGY , vol.23, no.3, pp.148-149, 2017
Emekli, A. S. (2017) . "Amiselimod: A New Oral Agent in the Treatment of Multiple Sclerosis." TURKISH JOURNAL OF NEUROLOGY , vol.23, no.3, pp.148-149.
@article{article, author={Ahmed Serkan Emekli}, title={Amiselimod: A New Oral Agent in the Treatment of Multiple Sclerosis}, journal={TURKISH JOURNAL OF NEUROLOGY}, year=2017, pages={148-149} }